Shareholder Votes

DocGo Inc. shareholders approved To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 to be determined in the sole discretion of the Company’s Board of Directors. at the 2026-06-16 meeting.

“3. To approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-5, 1-for-6, 1-for-7, 1-for-8, 1-for-9 or 1-for-10 to be determined in the sole discretion of the Company’s Board of Directors. Votes For Votes Against Abstentions Broker Non-Votes 66,141,612 5,673,628 199,608 — Pursuant to the foregoing vote, the stockholders approved the proposed reverse stock split.”

DocGo Inc. shareholders approved To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers at the 2026-06-16 meeting.

“2. To approve on a non-binding, advisory basis the compensation of the Company’s named executive officers: Votes For Votes Against Abstentions Broker Non-Votes 39,768,972 10,213,238 183,325 21,849,313 Pursuant to the foregoing vote, the stockholders approved on a non-binding, advisory basis the compensation of the Company’s named executive officers.”

DocGo Inc. shareholders approved Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified at the 2026-06-16 meeting.

“1. Election of the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Director Nominee Votes For Votes Withheld Broker Non-Votes Vina Leite 31,241,093 18,924,442 21,849,313 James M. Travers 25,062,607 25,102,928 21,849,313 Pursuant to the foregoing votes, the two nominees listed above were elected to serve on the Company’s Board of Directors.”

M-tron Industries, Inc. shareholders approved Ratification of the appointment of PKF O'Connor Davies, LLP as independent auditor for 2026 at the 2026-06-16 meeting.

“Proposal 4 - Ratification of the Appointment of PKF O'Connor Davies, LLP to Serve as the Company's Independent Auditor for 2026: The voting results were as follows: For Against Abstain Broker Non-votes 3,069,703 646 21,355 —”

M-tron Industries, Inc. shareholders approved Approval of the Second Amended and Restated M-tron Industries, Inc. 2022 Incentive Plan at the 2026-06-16 meeting.

“Proposal 3 - Approval of the Second Amended and Restated M-tron Industries, Inc. 2022 Incentive Plan: The voting results were as follows: For Against Abstain Broker Non-votes 1,396,029 531,891 128,647 1,035,137”

M-tron Industries, Inc. shareholders approved Advisory vote to approve named executive officer compensation at the 2026-06-16 meeting.

“Proposal 2 - Advisory Vote to Approve Named Executive Officer Compensation: The voting results were as follows: For Against Abstain Broker Non-votes 2,006,857 43,740 5,970 1,035,137”

M-tron Industries, Inc. shareholders approved Election of seven directors at the 2026-06-16 meeting.

“Proposal 1 - Election of Directors: The following individuals were elected to serve as directors until the 2027 Annual Meeting or upon the election and qualification of their successors. The voting results for each of the nominees were as follows Nominee For Withheld Broker Non-votes Ivan Arteaga 2,010,287 46,280 1,035,137 Marc Gabelli 1,495,544 561,023 1,035,137 David M. Goldman 2,005,745 50,822 1,035,137 Robert V. La Penta Jr. 1,962,075 94,492 1,035,137 Bel Lazar 1,945,702 110,865 1,035,137 John S. Mega 1,737,402 319,165 1,035,137 Hendi Susanto 2,006,070 50,497 1,035,137”

Match Group, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026 fiscal year at the 2026-06-16 meeting.

“4. The Auditor Ratification Proposal —stockholders ratified the appointment of Ernst & Young LLP as Match Group's independent registered public accounting firm for the 2026 fiscal year. Stockholders eligible to vote voted as follows: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstaining 199,786,113 8,768,634 96,369”

Match Group, Inc. shareholders approved The Second Amended and Restated 2024 Stock and Annual Incentive Plan at the 2026-06-16 meeting.

“3. The Second Amended and Restated 2024 Stock and Annual Incentive Plan —stockholders approved the Match Group, Inc. Second Amended and Restated 2024 Stock and Annual Incentive Plan. Stockholders eligible to vote voted as follows: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstaining 133,116,903 66,173,398 67,360 In addition to the votes cast and abstentions described above, there were 9,293,455 broker non-votes with respect to the Second Amended and Restated 2024 Stock and Annual Incentive Plan.”

Match Group, Inc. shareholders rejected The Say on Pay Proposal at the 2026-06-16 meeting.

“2. The Say on Pay Proposal —stockholders did not approve, on an advisory basis, the compensation paid to Match Group’s named executive officers for the fiscal year ended December 31, 2025. Stockholders eligible to vote voted as follows: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstaining 85,252,504 114,012,022 93,135 In addition to the votes cast and abstentions described above, there were 9,293,455 broker non-votes with respect to the Say on Pay Proposal.”

Match Group, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.

“1. Election of Directors —stockholders elected the following four directors of Match Group, each to hold office for a one-year term ending on the date of the annual meeting of Match Group's stockholders in 2027 or until such director's successor shall have been duly elected and qualified (or, if earlier, such director's removal or resignation from the Board of Directors of Match Group). Stockholders eligible to vote voted as follows: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstaining Manuel Bronstein 197,705,763 494,532 1,157,366 Laura Rachel Jones 196,362,251 2,945,979 49,431 Ann L. McDaniel 164,627,554 34,663,099 67,008 Thomas J. McInerney 192,619,830 6,649,648 88,183 In addition to the votes cast and abstentions for each director nominee described above, there were 9,293,455 broker non-votes with respect to each director nominee.”

RECURSION PHARMACEUTICALS, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-17 meeting.

“Proposal 3: The appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026 was ratified, with the following votes cast: For Against Abstain 361,743,500 2,148,771 1,128,498”

RECURSION PHARMACEUTICALS, INC. shareholders approved Advisory vote to approve executive compensation at the 2026-06-17 meeting.

“Proposal 2: The advisory resolution to approve executive compensation, as disclosed in the Proxy Statement, was approved, with the following votes cast: For Against Abstain Broker Non-Votes 206,171,008 30,893,147 1,280,852 126,675,762”

RECURSION PHARMACEUTICALS, INC. shareholders approved Election of Class II directors at the 2026-06-17 meeting.

“Proposal 1: The stockholders elected as Class II directors the two individuals listed below to serve until the Company’s 2029 annual meeting of stockholders, or until their respective successors are duly elected and qualified. The voting results were as follows: Nominee For Withheld Broker Non-Votes Najat Khan, Ph.D. 210,437,751 27,907,256 126,675,762 Franziska Michor, Ph.D. 208,124,737 30,220,270 126,675,762”

Zura Bio Ltd shareholders approved Approval of the Amended and Restated 2023 Zura Bio Limited Equity Incentive Plan at the 2026-06-17 meeting.

“Proposal 3 - Approval of the Amended and Restated 2023 Zura Bio Limited Equity Incentive Plan The Company's shareholders approved the amendment and restatement of the Company's 2023 Equity Incentive Plan. The votes cast were as follows: For Against Abstain Broker Non-Votes 38,850,373 17,403,607 26,663 18,267,509”

Zura Bio Ltd shareholders approved Ratification of the appointment of WithumSmith+Brown, PC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 2 - Ratification of the Appointment of Independent Registered Public Accounting Firm. The Company's shareholders ratified the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes cast were as follows: For Against Abstain 74,323,697 30,527 193,928”

Zura Bio Ltd shareholders approved Election of eight director nominees at the 2026-06-17 meeting.

“Proposal 1 - Election of Directors. The Company's shareholders elected the Director Nominees as directors of the Company, each to hold office until the next annual general meeting of shareholders or until their respective successors have been elected and qualified, or until their earlier death, resignation or removal. The votes cast were as follows: Nominee For Against Abstain Broker Non-Votes Daniel Becker 55,968,512 291,173 20,958 18,267,509 Mark Eisner 56,209,068 49,466 22,109 18,267,509 Jennifer Jarrett 39,788,639 16,471,044 20,958 18,267,511 Sandeep Kulkarni 56,250,391 8,292 21,960 18,267,509 Amit Munshi 40,229,829 16,027,697 23,115 18,267,511 Ajay Nirula 56,249,212 8,319 23,113 18,267,508 Steven Schoch 56,197,526 61,025 22,093 18,267,508 Parvinder Thiara 55,766,669 490,857 23,115 18,267,511”

Calidi Biotherapeutics, Inc. shareholders approved 2023 Plan Amendment at the 2026-06-12 meeting.

“Stockholders approved an amendment to the Company’s 2023 Equity Incentive Plan (the “2023 Plan”), to increase the aggregate number of shares of common stock authorized for grant under the 2023 Plan from 282,815 to 1,950,000.”

Calidi Biotherapeutics, Inc. shareholders approved Reverse Stock Split at the 2026-06-12 meeting.

“Stockholders approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation, as amended, to, at the discretion of the Board of Directors, effect a reverse stock split with respect to the Company’s shares of issued and outstanding Common Stock, which consists of Voting Common Stock and Non-Voting Common Stock, at a ratio between 1-for-2 and 1-for-16 (the “Range”), with the ratio within such Range to be determined at the discretion of the Board and included in a public announcement.”

Calidi Biotherapeutics, Inc. shareholders approved Ratification of the appointment of Auditor at the 2026-06-12 meeting.

“Stockholders approved and ratified the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm to audit the consolidated financial statements of the Company for the fiscal year ending December 31, 2026.”

Calidi Biotherapeutics, Inc. shareholders approved Election of Class III Director Nominee at the 2026-06-12 meeting.

“The stockholders elected Scott Leftwich as Class III Director of the Company by a plurality of the votes cast, and without contest, to serve a three-year term until the 2029 Annual Meeting of Stockholders or until his successor has been duly elected.”

Contango Silver & Gold Inc. shareholders approved To conduct a non-binding advisory vote on the frequency of the advisory vote on the compensation of the company's named executive officers at the 2026-06-18 meeting.

“4. Proposal 4 : The stockholders approved, on a non-binding advisory, the frequency of the advisory vote on the compensation of the company's named executive officers. In light of these results, the Board determined that the Company will hold an advisory vote on the compensation of the Company's named executive officers every year. The Company will re-evaluate this determination in connection with its next stockholder advisory vote regarding the frequency of future advisory votes on the compensation of the Company's named executive officers at the Company's annual meeting of stockholders in 2032. 1 Year 2 Years 3 Years Abstain Broker Non-Votes 13,135,398 1,299,463 89,695 121,190 3,216,629”

Contango Silver & Gold Inc. shareholders approved To conduct a non-binding advisory vote to approve the compensation of the Company's named executive officers at the 2026-06-18 meeting.

“3. Proposal 3 : The stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers. For Against Abstain Broker Non-Votes 13,099,487 1,479,740 66,519 3,216,629”

Contango Silver & Gold Inc. shareholders approved To ratify the appointment of Baker Tilly US, LLP as the independent auditors of the Company for the fiscal year ending December 31, 2026 at the 2026-06-18 meeting.

“2. Proposal 2 : The stockholders ratified the appointment of Baker Tilly US, LLP as the independent auditors of the Company for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes 17,784,572 42,963 34,840 0”

Contango Silver & Gold Inc. shareholders approved To elect seven persons to serve as directors of the Company until the annual meeting of stockholders in 2027 at the 2026-06-18 meeting.

“1. Proposal 1 : Each of the director nominees was elected to the Board to serve as a director until the 2027 annual meeting of stockholders of the Company and until his respective successor is duly elected and qualified. Name For Withheld Broker Non-Votes Clynton Nauman 14,417,465 228,281 3,216,629 Rick Van Nieuwenhuyse 14,464,535 181,211 3,216,629 Shawn Khunkhun 13,963,086 682,660 3,216,629 Michael Cinnamond 13,933,375 712,371 3,216,629 Tim Clark 14,427,965 217,781 3,216,629 Darren Devine 14,027,615 618,131 3,216,629 Brad Juneau 9,532,864 5,112,882 3,216,629”

Brilliant Earth Group, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm. Votes For Votes Against Abstained Broker Non-Votes 536,108,294 111,934 1,892 0”

Brilliant Earth Group, Inc. shareholders approved Election of Class II Directors at the 2026-06-17 meeting.

“Proposal 1: Election of Class II Directors. Nominee Votes For Votes Withheld Broker Non-Votes Eric Grossberg 528,614,937 1,267,353 6,339,830 Attica A. Jaques 528,734,945 1,147,345 6,339,830 Gavin M. Turner 529,774,755 107,535 6,339,830”

SUPERNUS PHARMACEUTICALS, INC. shareholders approved To act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the Plan. at the 2026-06-18 meeting.

“Proposal 4: To act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan (the "Plan") to increase the number of shares available under the Plan. Votes For Votes Against Abstain Broker Non-Votes 41,925,692 5,302,088 7,922 3,073,181”

SUPERNUS PHARMACEUTICALS, INC. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-18 meeting.

“Proposal 3: Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstain Broker Non-Votes 49,882,228 417,336 9,319 0”

SUPERNUS PHARMACEUTICALS, INC. shareholders approved To approve, on a non-binding basis, the compensation paid to our named executive officers. at the 2026-06-18 meeting.

“Proposal 2: To approve, on a non-binding basis, the compensation paid to our named executive officers. Votes For Votes Against Abstain Broker Non-Votes 45,552,633 1,675,355 7,714 3,073,181”

SUPERNUS PHARMACEUTICALS, INC. shareholders approved Election of Class I Directors at the 2026-06-18 meeting.

“Proposal 1: Election of Class I Directors, each to serve until the Annual Meeting of the Company in 2029. Name Votes For Votes Withheld Broker Non-Votes Frederick M. Hudson 45,058,634 2,177,068 3,073,181 Charles W. Newhall, III 41,743,154 5,492,548 3,073,181”

Sixth Street Specialty Lending, Inc. shareholders approved Sales of Common Stock Below NAV at the 2026-06-18 meeting.

“Proposal 1 – Sales of Common Stock Below NAV. The stockholders approved the proposal to authorize the Company to sell or otherwise issue shares of its common stock at a price below its then-current net asset value per share in one or more offerings, in each case subject to the approval of its board of directors and subject to certain conditions as set forth in the proxy statement (including that the number of shares issued does not exceed 25% of the Company’s then-outstanding common stock immediately prior to each such offering), by the vote shown below. The vote on the proposal, including affiliated and unaffiliated shares, was as follows: Votes “For” Votes “Against” Abstentions Broker Non-Votes 41,423,791 6,674,197 1,818,545 0”

CENTRUS ENERGY CORP shareholders approved Ratification of Deloitte & Touche LLP as independent auditors for 2026. at the 2026-06-18 meeting.

“The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditors for 2026 as follows: For Against Abstain Broker Non-Votes 12,548,012 55,847 152,147 0”

CENTRUS ENERGY CORP shareholders approved Approval of Section 382 Rights Agreement, as amended by the Seventh Amendment. at the 2026-06-18 meeting.

“The Company’s stockholders cast their votes with respect to the approval of the Section 382 Rights Agreement, as amended by the Seventh Amendment, as follows: For Against Abstain Broker Non-Votes 7,664,845 853,077 159,884 4,078,200”

CENTRUS ENERGY CORP shareholders approved Amendment to the Amended and Restated Certificate of Incorporation to permit exculpation of officers. at the 2026-06-18 meeting.

“The Company’s stockholders cast their votes as follows with respect to the approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to permit the exculpation of officers to be included in the Second Amended and Restated Certificate of Incorporation: For Against Abstain Broker Non-Votes 6,724,942 1,801,154 151,710 4,078,200”

CENTRUS ENERGY CORP shareholders approved Advisory vote on executive compensation (say-on-pay). at the 2026-06-18 meeting.

“The Company’s stockholders cast their votes with respect to the approval on an advisory basis of the Company’s executive compensation (i.e., "say-on-pay") as follows: For Against Abstain Broker Non-Votes 8,144,054 380,092 153,660 4,078,200”

CENTRUS ENERGY CORP shareholders approved Election of six directors to hold office until the next annual meeting. at the 2026-06-18 meeting.

“The Company’s stockholders elected six directors (listed below) to hold office until the next annual meeting of stockholders and until his or her successor is elected and has qualified.”

Douglas Elliman Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-18 meeting.

“Proposal 3: Advisory vote on executive compensation (the “say-on-pay” vote). The advisory vote to approve the compensation of the Company’s named executive officers received the following votes: For Against Abstain (1) Broker Non-Votes (1) 34,611,231 21,224,428 7,954,183 13,202,845”

Douglas Elliman Inc. shareholders approved Ratification of the appointment of EisnerAmper LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-18 meeting.

“Proposal 2: Ratification of the appointment of EisnerAmper LLP as independent registered public accounting firm for the year ending December 31, 2026. The selection of the independent registered public accounting firm received the following votes: For Against Abstain (1) 73,917,755 3,006,249 68,682”

Douglas Elliman Inc. shareholders approved Election of directors at the 2026-06-18 meeting.

“Proposal 1: Election of directors. Each of the directors nominated was elected based on the following votes: Nominee For Withheld Broker Non-Votes (1) Michael S. Liebowitz 49,539,304 14,250,538 13,202,845 Mark D. Zeitchick 35,627,229 28,162,613 13,202,845”

Elauwit Connection, Inc. shareholders voted on Adjournment proposal to solicit additional votes if necessary at the 2026-06-18 meeting.

“The Company’s stockholders approved a proposal to adjourn the Annual Meeting from time to time, if necessary or appropriate, including to solicit additional votes in favor of Proposal One and/or Proposal Two”

Elauwit Connection, Inc. shareholders approved Ratification of WithumSmith+Brown, PC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-18 meeting.

“The Company’s stockholders ratified the selection of WithumSmith+Brown, PC (“Withum”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Elauwit Connection, Inc. shareholders approved Election of three directors for three-year terms expiring in 2029 at the 2026-06-18 meeting.

“The Company’s stockholders elected three directors, each for a three-year term expiring in 2029”

Xencor Inc shareholders approved Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2026-06-16 meeting.

“The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of its named executive officers as disclosed in the Proxy Statement.”

Xencor Inc shareholders approved Approval of the Amendment and Restatement of the Xencor, Inc. 2023 Equity Incentive Plan to Increase the Number of Authorized Shares Available for Issuance thereunder by 4,000,000 Shares at the 2026-06-16 meeting.

“The Company’s stockholders approved the amendment and restatement of the Xencor, Inc. 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares.”

Xencor Inc shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.

“The Company’s stockholders ratified the selection by the Audit Committee of the Board of Directors of KPMG LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Xencor Inc shareholders approved Election of Directors at the 2026-06-16 meeting.

“The Company’s stockholders elected the nine persons listed below as directors, each to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified.”

Clipper Realty Inc. shareholders approved Approval (on non-binding, advisory basis) of the compensation of the Company's named executive officers at the 2026-06-17 meeting.

“Proposal 3 : The approval (on non-binding, advisory basis) of the compensation of the Company's named executive officers. For Against Abstain 30,337,150 539,500 23,926”

Clipper Realty Inc. shareholders approved Ratification of the appointment of PKF O’Connor Davies, LLP, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

“Proposal 2 : The ratification of the appointment of PKF O’Connor Davies, LLP, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain 35,636,092 29,649 7,976”

Clipper Realty Inc. shareholders approved Election of the seven director nominees named in the Proxy Statement at the 2026-06-17 meeting.

“Proposal 1 : The election of the seven director nominees named in the Proxy Statement.”